Valiant Evo International Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

March 2, 2023

Conditions
Aortic Aneurysm, Thoracic
Interventions
DEVICE

Valiant Evo Thoracic Stent Graft System

Procedure: thoracic endovascular aneurysm repair (TEVAR)

Trial Locations (16)

Unknown

London Health Sciences Centre - Victoria Hospital, London

Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ), Québec

Odense Universitetshospital, Odense

Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson

CHU de Montpellier - Hôpital Arnaud de Villeneuve, Montpellier

Hôpitaux Universitaires de Strasbourg - Nouvel Hôpital Civil, Strasbourg

Policlinico Sant' Orsola - Malpighi, Bologna

IRCCS Ca' Granda Ospendale Maggiore Policlinico, Milan

Ospedale San Raffaele - Milano, Milan

Università di Perugia - Ospedale S.M. Della Misericordia, Perugia

IRCCS Policlinico San Donato, San Donato Milanese

Maastricht Universitair Medisch Centrum (MUMC), Maastricht

St. Antonius Ziekenhuis, Nieuwegein

Cambridge University Hospitals NHS Foundation Trust - Addenbrooke's Hospital, Cambridge

Imperial College Healthcare NHS Trust - St Mary's Hospital, London

Saint George's Healthcare NHS Trust, London

Sponsors
All Listed Sponsors
lead

Medtronic Cardiovascular

INDUSTRY

NCT02625324 - Valiant Evo International Clinical Trial | Biotech Hunter | Biotech Hunter